[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2022, "totalPay": 481131, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2022, "totalPay": 182540, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2022, "totalPay": 306088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 61, "title": "Chief Medical Officer & Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 364262, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.46, "open": 1.5, "dayLow": 1.5, "dayHigh": 1.95, "regularMarketPreviousClose": 1.46, "regularMarketOpen": 1.5, "regularMarketDayLow": 1.5, "regularMarketDayHigh": 1.95, "beta": 0.752, "forwardPE": -5.2000003, "volume": 1115674, "regularMarketVolume": 1115674, "averageVolume": 379029, "averageVolume10days": 263830, "averageDailyVolume10Day": 263830, "bid": 1.81, "ask": 1.86, "bidSize": 100, "askSize": 100, "marketCap": 118507304, "fiftyTwoWeekLow": 0.45, "fiftyTwoWeekHigh": 2.17, "fiftyDayAverage": 1.39826, "twoHundredDayAverage": 1.023325, "currency": "USD", "enterpriseValue": 78148448, "floatShares": 62170145, "sharesOutstanding": 65113900, "sharesShort": 361076, "sharesShortPriorMonth": 148794, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0055, "heldPercentInsiders": 0.0396, "heldPercentInstitutions": 0.13428001, "shortRatio": 0.65, "shortPercentOfFloat": 0.0058, "impliedSharesOutstanding": 65898800, "bookValue": 0.538, "priceToBook": 3.3828998, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -28006292, "trailingEps": -0.32, "forwardEps": -0.35, "enterpriseToEbitda": -2.546, "52WeekChange": 2.669355, "SandP52WeekChange": 0.29191303, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CRDL", "underlyingSymbol": "CRDL", "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "firstTradeDateEpochUtc": 1547562600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ee9d962b-eed4-3063-8df9-c815990fe5d8", "messageBoardId": "finmb_424954803", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.82, "targetHighPrice": 5.94, "targetLowPrice": 5.94, "targetMeanPrice": 5.94, "targetMedianPrice": 5.94, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 40540136, "totalCashPerShare": 0.623, "ebitda": -30690260, "totalDebt": 181206, "quickRatio": 5.085, "currentRatio": 5.286, "debtToEquity": 0.52, "returnOnAssets": -0.34614, "returnOnEquity": -0.59876, "freeCashflow": -16223832, "operatingCashflow": -31261212, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-03-27"}]